KRP203

KRP-203 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KRP203, covering 2017-03-22 to 2017-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus [Phase 2]